A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups

por Rickard, Emily, Ozieranski, Piotr
Publicado 2021

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis

por Rickard, Emily, Carmel, Emma, Ozieranski, Piotr
Publicado 2023

Exposing drug industry funding of UK patient organisations

por Ozieranski, Piotr, Rickard, Emily, Mulinari,, Shai
Publicado 2019

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs

por Mulinari, Shai, Vilhelmsson, Andreas, Rickard, Emily, Ozieranski, Piotr
Publicado 2020

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)

por Ozieranski, Piotr, Csanádi, Marcell, Rickard, Emily, Mulinari, Shai
Publicado 2020

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

por Ozieranski, Piotr, Csanadi, Marcell, Rickard, Emily, Tchilingirian, Jordan, Mulinari, Shai
Publicado 2019

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency

por Ozieranski, Piotr, Saito, Hiroaki, Rickard, Emily, Mulinari, Shai, Ozaki, Akihiko
Publicado 2023